Prevalence, Factors and Impact of Migraine on Healthcare Professionals: A cross-sectional study in the United Arab Emirates
Abstract
Summary Objectives: This study aimed to determine the prevalence of migraines among healthcare professionals (HCPs) in the United Arab Emirates (UAE), identify associated factors and evaluate their impact on quality of life (QoL) and work performance. Methods: This cross-sectional study was conducted from January to June 2022 and included nurses and doctors across 4 healthcare settings in the UAE. Migraine prevalence was assessed using the Migraine Screen Questionnaire, while its impact on social support and work function was evaluated through the Migraine Disability Assessment, the Oslo Social Support Scale and the Headache Impact Test. Data were analysed using Chi-square tests, binary logistic regression and multivariable logistic regression. Results: A total of 440 nurses and doctors were included. Migraine prevalence among participants was 18.2%. The likelihood of experiencing migraines was significantly higher among females (odds ratio [OR] = 2.99, 95% confidence interval [CI]: 1.1–7.9), individuals with a family history of migraines (OR = 2.17, 95% CI: 1.1–4.3), those reporting stress (OR = 5.87, 95% CI: 2.9–11.8), sleep deprivation (OR = 4.38, 95% CI: 1.9–9.8), motion sickness (OR = 5.06, 95% CI: 1.7–15.5) and specific food triggers (OR = 11.29, 95% CI: 3.1–41.2). Participants with migraines reported significantly higher rates of disability (29.1% versus 3.4%; P <0.001) and severe work function impairment (54.4% versus 17.1%; P <0.001). Additionally, migraines were…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.